It uses a type of medicine called GLP-1 agonists
TB-500 works through mechanisms distinct from BPC-157, despite some overlap in outcomes
Its also advisable not to consume alcohol excessively, as it may increase the risk of pancreatitis
Analytical Verification HPLC peptide analysis and LC-MS verification support peptide identity, purity evaluation, analytical consistency, and reproducible laboratory research
A phase III, randomized, double-blind, placebo-controlled trial, which was open-label for the comparator liraglutide group, evaluated dulaglutide monotherapy (0.75 mg) versus placebo versus once-daily liraglutide in individuals with T2DM